Pure Global

“Vircell” CYTOMEGALOVIRUS VIRCLIA IgM MONOTEST - Taiwan Registration 7fa61e5a95e4776685aa1a33ef26572c

Access comprehensive regulatory information for “Vircell” CYTOMEGALOVIRUS VIRCLIA IgM MONOTEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7fa61e5a95e4776685aa1a33ef26572c and manufactured by VIRCELL, S.L. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7fa61e5a95e4776685aa1a33ef26572c
Registration Details
Taiwan FDA Registration: 7fa61e5a95e4776685aa1a33ef26572c
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Vircell” CYTOMEGALOVIRUS VIRCLIA IgM MONOTEST
TW: “凡賽爾”巨細胞病毒化學冷光免疫分析IgM試劑組
Risk Class 2
MD

Registration Details

7fa61e5a95e4776685aa1a33ef26572c

Ministry of Health Medical Device Import No. 032151

DHA05603215102

Company Information

Spain

Product Details

This product is an indirect chemiluminescent immunoassay (CLIA) reagent, combined with Thunderbolt Immunoassay Analyzer, to qualitatively detect anti-cytomegalovirus IgM antibodies in human plasma.

C Immunology and microbiology devices

C3175 CMV serum reagent

Imported from abroad

Dates and Status

Jan 25, 2019

Jan 25, 2024